Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rafii

Showing results (171-180 of 220) with videos related to

Pageof 22
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Multi-organ MRI digitizes biological aging clocks across proteomics, metabolomics, and genetics, Huizi Cao, Zhiyuan Song, et al.
Molecular Autism|January 29, 2026
Serum and cerebral folate are normal in down syndrome regression disorderJonathan D Santoro, Mackenzie Silverman, Lilia Kazerooni, et al.
Scientific Reports|December 28, 2024
Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorderJonathan D Santoro, Saba Jafarpour, Laura Keehan, et al.
The Journal of Prevention of Alzheimer'S Disease|April 8, 2026
Late-life body mass index and amyloid interaction on cognitive decline in unimpaired older adultsWai-Ying Wendy Yau, Rema Raman, Jasmeer Chhatwal, et al.
Neurology|April 7, 2017
A phase 3 trial of IV immunoglobulin for Alzheimer diseaseNorman R Relkin, Ronald G Thomas, Robert A Rissman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersJason K Russell, Alexander C Conley, Brian Boyd, et al.
Scientific Reports|December 3, 2024
Effects of the therapeutic correction of U1 snRNP complex on Alzheimer's diseaseCaio Bruno Q S Leal, Camila G M Zimmer, Vanessa V C Sinatti, et al.
Neurobiology of Aging|February 6, 2025
Differences in cholinergic terminal density in adults with Down syndrome compared to neurotypical controls measured by [<sup>18</sup>F]-fluoroethoxybenzovesamicol positron emission tomography imagingJason K Russell, Alexander C Conley, Brian D Boyd, et al.
The New England Journal of Medicine|July 17, 2023
Trial of Solanezumab in Preclinical Alzheimer's DiseaseReisa A Sperling, Michael C Donohue, Rema Raman, et al.
American Journal of Medical Genetics. Part A|January 3, 2024
Safety and tolerability of intravenous immunoglobulin infusion in Down syndrome regression disorderJonathan D Santoro, Saba Jafarpour, Mellad M Khoshnood, et al.
Pageof 22

Showing results (171-180 of 220) with videos related to

Sort By:
Pageof 22
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Multi-organ MRI digitizes biological aging clocks across proteomics, metabolomics, and genetics, Huizi Cao, Zhiyuan Song, et al.
Molecular Autism|January 29, 2026
Serum and cerebral folate are normal in down syndrome regression disorderJonathan D Santoro, Mackenzie Silverman, Lilia Kazerooni, et al.
Scientific Reports|December 28, 2024
Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorderJonathan D Santoro, Saba Jafarpour, Laura Keehan, et al.
The Journal of Prevention of Alzheimer'S Disease|April 8, 2026
Late-life body mass index and amyloid interaction on cognitive decline in unimpaired older adultsWai-Ying Wendy Yau, Rema Raman, Jasmeer Chhatwal, et al.
Neurology|April 7, 2017
A phase 3 trial of IV immunoglobulin for Alzheimer diseaseNorman R Relkin, Ronald G Thomas, Robert A Rissman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersJason K Russell, Alexander C Conley, Brian Boyd, et al.
Scientific Reports|December 3, 2024
Effects of the therapeutic correction of U1 snRNP complex on Alzheimer's diseaseCaio Bruno Q S Leal, Camila G M Zimmer, Vanessa V C Sinatti, et al.
Neurobiology of Aging|February 6, 2025
Differences in cholinergic terminal density in adults with Down syndrome compared to neurotypical controls measured by [<sup>18</sup>F]-fluoroethoxybenzovesamicol positron emission tomography imagingJason K Russell, Alexander C Conley, Brian D Boyd, et al.
The New England Journal of Medicine|July 17, 2023
Trial of Solanezumab in Preclinical Alzheimer's DiseaseReisa A Sperling, Michael C Donohue, Rema Raman, et al.
American Journal of Medical Genetics. Part A|January 3, 2024
Safety and tolerability of intravenous immunoglobulin infusion in Down syndrome regression disorderJonathan D Santoro, Saba Jafarpour, Mellad M Khoshnood, et al.
Pageof 22